Univ of California San Francisco Medical Center Mission Bay
Welcome,         Profile    Billing    Logout  
 7 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hope, Thomas A
NCT04895631: 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Recruiting
3
140
US
18F-Fluorocholine, Fluorocholine, Positron emission tomography (PET), PET
Thomas Hope
Hyperparathyroidism, Primary
06/26
06/27
NCT04716725: 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Active, not recruiting
2
15
US
68Ga-PSMA-11, 68Ga Prostate-specific Membrane Antigen (PSMA) 11, Gallium Ga-68 gozetotide, Gallium-68 PSMA, Gallium Ga 68 PSMA-11, Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography (PET), PET, PET Scan
Thomas Hope, Conquer Cancer Foundation, Gateway for Cancer Research, Prostate Cancer Foundation
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
09/23
04/25
NCT04665739: Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Recruiting
2
108
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Everolimus, 42-O-(2-Hydroxy)ethyl Rapamycin, Afinitor, Certican, RAD 001, RAD-001, RAD001, Votubia, Zortress, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Lutetium Lu 177 Dotatate, 177 Lu-DOTA-TATE, 177 Lu-DOTA-Tyr3-Octreotate, 177Lu-DOTA0-Tyr3-Octreotate, Lutathera, Lutetium (177Lu) Oxodotreotide, Lutetium Lu 177 DOTA(0)-Tyr(3)-Octreotate, Lutetium Lu 177-DOTA-Tyr3-Octreotate, lutetium Lu 177-DOTATATE, Lutetium Oxodotreotide Lu-177, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Single Photon Emission Computed Tomography, Medical Imaging, Single Photon Emission Computed Tomography, Single Photon Emission Tomography, Single-Photon Emission Computed, single-photon emission computed tomography, SPECT, SPECT imaging, SPECT SCAN, SPET, ST, tomography, emission computed, single photon, Tomography, Emission-Computed, Single-Photon, Survey Administration
National Cancer Institute (NCI)
Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Tumor G1, Lung Neuroendocrine Tumor G2, Metastatic Lung Neuroendocrine Neoplasm, Metastatic Lung Neuroendocrine Tumor, Non-Functioning Lung Neuroendocrine Tumor, Recurrent Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Tumor
07/25
07/25
NCT04044937: Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

Completed
2
143
US
F-18 Fluoroethyltyrosine (FET), 18F-FET, 18FET, 2''-[F18] Fluoro-ethyl-L-tyrosine, [18F]-Fluoro-ethyl-L-tyrosine, Fluorine-18 2''-Fluoroethyl-L-tyrosine, Fluoroethyltyrosine F18, O-(2[F18]fluoroethyl)-L-tyrosine, Positron Emission Tomography (PET), Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron Emission Tomography, Positron Emission Tomography Scan, proton magnetic resonance spectroscopic imaging
Thomas Hope
Intracranial Neoplasm, Low Grade Glioma, Recurrent Glioblastoma, Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma
03/24
03/24
NCT06526299: Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Recruiting
2
51
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Lutetium Lu 177 Vipivotide Tetraxetan, 177Lu-labeled PSMA-617, 177Lu-PSMA-617, AAA 617, AAA-617, AAA617, Lu177-PSMA-617, Lutetium Lu 177-PSMA-617, LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN, Lutetium-177-PSMA-617, Pluvicto, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, PSMA PET-CT Scan, PET-CT (PSMA), Prostate-specific Membrane Antigen PET-CT, PSMA PET-CT, Questionnaire Administration, Single Photon Emission Computed Tomography, Medical Imaging, Single Photon Emission Computed Tomography, Single Photon Emission Tomography, Single-Photon Emission Computed, single-photon emission computed tomography, SPECT, SPECT imaging, SPECT SCAN, SPET, ST, tomography, emission computed, single photon, Tomography, Emission-Computed, Single-Photon
University of Washington, Novartis, Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mars Shot Research Fund
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
12/27
12/27
NCT05924672: Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Recruiting
2
54
US
Radium-223, Ra-223, BAY 88-8223, BAY88-8223, Radium 223 Dichloride, Xofigo, PSMA Positron Emission Tomography (PET) Scan, Prostate-specific Membrane Antigen (PSMA) PET, PSMA PET, Technetium Tc 99M Medronate, (99m)Tc-Medronate, 121524-79-6, 99mTc-MDP, TechneScan MDP, Technetium Tc 99m Methylene Diphosphonate
University of California, San Francisco, Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Stage IVB Prostate Cancer AJCC v8
05/26
05/28
LuMIERE, NCT04939610: A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

Checkmark Safety and efficacy data from P1 portion of P1/2 LuMIERE trial for solid tumors
Jul 2022 - Jul 2022: Safety and efficacy data from P1 portion of P1/2 LuMIERE trial for solid tumors
Recruiting
1/2
222
US
68Ga-FAP-2286, 177Lu-FAP-2286
Novartis Pharmaceuticals
Solid Tumor
06/26
06/28
NCT04976257: Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Completed
1
5
US
Angiogram, Catheterization, Gallium Ga-labeled PSMA-11, 68Ga-PSMA-11, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging
Ryan Kohlbrenner, MD, Radiological Society of North America
Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
03/23
03/23
NCT05180162: Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

Recruiting
1
30
US
68Ga-FAP-2286, 68Gallium-Fibroblast Activation Protein-2286, Positron Emission Tomography (PET), PET Imaging, PET Scan
Thomas Hope, Clovis Oncology, Inc.
Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis
12/24
12/24
68Ga-FAP-2286, NCT04621435: Imaging of Solid Tumors Using FAP-2286

Recruiting
1
131
US
Gallium-68 labelled (68Ga-) FAP-2286, 68Ga-FAP-2286, Positron Emission Tomography (PET) imaging, PET, Copper-64 labeled (64Cu-) FAP-2286, 64Cu-FAP-2286
Thomas Hope, Society of Abdominal Radiology
Solid Tumors, Adult, Metastatic Cancer
12/25
12/25
NCT05435495: Mechanisms of Resistance to PSMA Radioligand Therapy

Recruiting
N/A
125
US
Single-photon emission computed tomography, SPECT/CT, Blood Draw, Tumor Biopsy, Biopsy
University of California, San Francisco, National Cancer Institute (NCI), Prostate Cancer Foundation
Prostate Cancer
12/25
12/25
NCT06474533: Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

Recruiting
N/A
199
US
Fluorethyltyrosine (18-F), Fluoroethyltyrosine (FET), FET, O-(2-[18F]fluoroethyl)-L-tyrosine (FET), Positron Emission Tomography (PET), PET scan, PET
Thomas Hope
Intracranial Neoplasm
08/28
08/28
NCT06630845: Comparison of Whole Body DWI to FDG PET

Not yet recruiting
N/A
30
US
Fluorodeoxyglucose F18, Fludeoxyglucose F18 (FDG), 2-deoxy-2-[fluorine-18]fluoro-D-glucose, Fluorodeoxyglucose, Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI), PET/MRI, Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI), WB-MRI-DWI, General Electric (GE) SIGNA PET/MR, GE SIGNA PET/MR, SIGNA PET/MR
University of California, San Francisco, Society of Abdominal Radiology, GE Healthcare
Metastatic Cancer
10/27
10/29

Download Options